ESSA Pharma Statistics

Total Valuation

ESSA Pharma has a market cap or net worth of $79.42 million. The enterprise value is -$53.59 million.

Market Cap	79.42M
Enterprise Value	-53.59M

Important Dates

The next estimated earnings date is Tuesday, December 10, 2024, before market open.

Earnings Date	Dec 10, 2024
Ex-Dividend Date	n/a

Share Statistics

ESSA Pharma has 44.37 million shares outstanding. The number of shares has increased by 0.28% in one year.

Current Share Class	44.37M
Shares Outstanding	44.37M
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	2.22%
Owned by Institutions (%)	46.57%
Float	20.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.60
P/TBV Ratio	0.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 36.95, with a Debt / Equity ratio of 0.00.

Current Ratio	36.95
Quick Ratio	36.61
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-30,218.60

Financial Efficiency

Return on equity (ROE) is -19.83% and return on invested capital (ROIC) is -15.15%.

Return on Equity (ROE)	-19.83%
Return on Assets (ROA)	-14.79%
Return on Capital (ROIC)	-15.15%
Revenue Per Employee	n/a
Profits Per Employee	-$553,379
Employee Count	50
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.84% in the last 52 weeks. The beta is 1.84, so ESSA Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	-66.84%
50-Day Moving Average	4.73
200-Day Moving Average	6.14
Relative Strength Index (RSI)	25.40
Average Volume (20 Days)	2,417,646

Short Selling Information

Short Interest	1.15M
Short Previous Month	1.15M
Short % of Shares Out	4.30%
Short % of Float	n/a
Short Ratio (days to cover)	30.53

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.88M
Pretax Income	-27.67M
Net Income	-27.67M
EBITDA	n/a
EBIT	-33.88M
Earnings Per Share (EPS)	-$0.63

Full Income Statement

Balance Sheet

The company has $130.69 million in cash and $342,142 in debt, giving a net cash position of $130.35 million or $2.94 per share.

Cash & Cash Equivalents	130.69M
Total Debt	342,142
Net Cash	130.35M
Net Cash Per Share	$2.94
Equity (Book Value)	128.86M
Book Value Per Share	2.90
Working Capital	128.52M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-23.84M
Capital Expenditures	n/a
Free Cash Flow	-23.84M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESSA Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.28%
Shareholder Yield	-0.28%
Earnings Yield	-36.05%
FCF Yield	-31.06%

Analyst Forecast

The average price target for ESSA Pharma is $9.50, which is 430.73% higher than the current price. The consensus rating is "Hold".

Price Target	$9.50
Price Target Difference	430.73%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 25, 2018. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Apr 25, 2018
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1